Investor/Partnership

We seek equity investments from regional and/or global partners to co-develop our unique program through anticipated Phase II clinical trials. Please contact us to explore licensing and collaboration opportunities;

Prospective investors should direct inquiries to:

David R. Volk CEO CDG Therapeutics Inc.

312-301-8655

or

Steven Fleck CFO CDG Therapeutics Inc.

224-234-8515

 

Your Name (required)

Your Email (required)

Subject

Your Message